Reaction
Eczema Eyelids reporting signals
As of the last recalculation, Eczema Eyelids appears in 526 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is DUPILUMAB (PRR 54.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dupilumab | 297 | 54.7 | 54.8 |
| Levodopa | 8 | 26.6 | 26.6 |
| Crisaborole | 4 | 16.6 | 16.6 |
| Adapalene | 3 | 0.6 | 0.6 |